Protection of the Human Gut Microbiome From Antibiotics/Experiment 3/Signature 1
From BugSigDB
Needs review
Source: Supplementary table 3, Supplementary figure 1
Description: A detailed analysis of the MGSs that differed significantly between treatment groups
Abundance in Group 1: increased abundance in DAV132+moxifloxacin treated group (MXF+DAV132)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacillota | ||
| Lachnospiraceae |
Revision editor(s): WikiWorks
